Oral GLP-1 Medications: Orforglipron and Beyond The next frontier is oral GLP-1 medications like Orforglipron, developed by Eli Lilly
Ngi thng xuyn tip xc nh nng: Ngi lm vic ngoi tri, tip xc nhiu vi tia UV, khi bi hoc nh sng xanh t my tnh
With the popularity of GLP-1 drugs skyrocketing, it is likely that the analysis of these drugs will be more prolific than ever
PMID: Summary Keywords GLP-1 receptor agonists, medullary thyroid carcinoma, mRNA expression, papillary thyroid carcinoma, TCGA database Citation Kennedy S, Thomas J, DArcy S, Odia I, Kamdar D, Pereira L, Scarola D, Miles B, Frank D, Taneja C, Seetharamu N and Mandal R (2026) Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy